期刊文献+

不同剂量阿托伐他汀治疗不稳定型心绞痛78例疗效分析 被引量:2

下载PDF
导出
摘要 目的:探讨不同剂量阿托伐他汀治疗不稳定型心绞痛的临床疗效。方法:将78例不稳定型心绞痛(UAP)患者随机分为治疗组和对照组,每组39例,对照组予硝酸酯类、β受体阻滞剂、钙拮抗剂、阿司匹林、氢氯吡格雷等常规药治疗并给予阿托伐他汀10mg,Qd。治疗组在对照组基础上改用阿托伐他汀80mg,Qa,两组疗程均为4周。结果:治疗组心绞痛的改善程度与对照组比较有显著性差异。结论:大剂量阿托伐他汀治疗UAP能稳定动脉粥样硬化斑块。显著改善心绞痛的症状。
出处 《医学信息(下旬刊)》 2011年第10期161-161,共1页 Medical information
  • 相关文献

参考文献2

二级参考文献55

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2[1]Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease [ J ]. Circulation, 1990,82: Ⅱ 38- Ⅱ 46.
  • 3[2]Kinlay S, Selwyn AP, Delagrange D, et al. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points[J]. Curr Opin Lipidol,1996,7:389-397.
  • 4[3]Davies M J, Rachardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage and smooth muscle cell content[ J ]. Br Heart J, 1993,69:377-381.
  • 5[4]Sato T, Takebayashi S, Kohchi K. Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina[J]. Atherosclerosis, 1987,68:191-197.
  • 6[5]Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture [J]. Circulation, 1994,90: 775-778.
  • 7[6]van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology[J]. Circulation, 1994,89:36-44.
  • 8[7]Frieman GD, Klatsky AL. Siegelaub AB. The leukocyte count as a predictor of myocardial infaretion[J]. N Engt J Med,1974,290:1275-1278.
  • 9[8]Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary angiography[ J ]. Am J Cardiol, 1984,53:997-999.
  • 10[9]Smith CW, Rothlein R, Hughes B J, et al. Recognition of the endothelial determinant of CD1s-dependent human neutrophil adherence and transendothelial migration[J]. J Clin Invest,1988,82:1746-1756.

共引文献2152

同被引文献36

  • 1郝玉明,张涛.不同剂量阿托伐他汀在不稳定型心绞痛患者的早期应用[J].临床心血管病杂志,2006,22(4):195-197. 被引量:9
  • 2李志彬,胡健.阿托伐他汀对ACS患者可溶性血管细胞黏附分子-1与P-选择素的影响[J].中国老年学杂志,2007,27(9):870-871. 被引量:1
  • 3陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 4Prabhakaran S, Romano JG. Current diagnosis and manage- ment of symptomatic intracranial atherosclerotic disease[ J ]. Curr Opin Neurol, 201.2, 25 : 18-26.
  • 5Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of in- tensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized con- trolled trial[ J]. JAMA, 2004, 291(9) : 1071-1080.
  • 6Jadad AR, Moore RA, Carroll D, et al. Assessing the qual- ity of reports of randomized clinical trials : is blinding neces- sary? [J]. Control Clin Trials, 1996, 17(1): 1-12.
  • 7Wells G, Sultan S, Chen L, et al. Indirect evidence : indirect treatment comparisons in meta-analysis [ M ]. Ottawa: Canadi- an Agency for Drugs and Technologies in Health, 2009.
  • 8Zhou P, Lu Z, Gao P,et al. Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic in- tracranial arterial stenosis: a single-center, randomized, sin- gle-blind, parallel-group study with one-year follow-up [ J ].Clin Neurol Neurosur g , 2014,120:6-13.
  • 9Yu CM, Zhang Q, Lain L, et al. Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid inti- mal-medial thickness in patients with coronary heart disease [J]. Heart, 2007, 93 (8) : 933-939.
  • 10Zhang X, Wang H, Liu S, et al. Intensive-dose atorvastatin regimen halts progression of atherosclerotic plaques in new- onset unstable angina with borderline vulnerable plaque le- sions[J]. J Cardiovasc Pharmacol Ther , 2013,18(2) :119- 125.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部